Cidara Therapeutics, Inc. (CDTX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Cidara Therapeutics, Inc. (CDTX)
Go deeper and ask any question about CDTX
Company Performance
Current Price
as of Sep 13, 2024$11.94
P/E Ratio
N/A
Market Cap
$84.04M
Description
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Metrics
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Other
- TickerCDTX
- Price$11.94+5.20%
Trading Information
- Market Cap$84.04M
- Float87.39%
- Average Daily Volume (1m)21,290
- Average Daily Volume (3m)28,695
- EPS-$24.92
Company
- Revenue$39.07M
- Rev Growth (1yr)-96.03%
- Net Income-$94.21M
- Gross Margin81.13%
- EBITDA Margin-3,656.95%
- EBITDA-$11.04M
- EV-$105.58M
- EV/Revenue-2.70
- P/EN/A
- P/S1.39
Documents
SEC Filings
Factset Street Account
Factset